Gilead's Sovaldi, GSK's Anoro stand out in 2014's blockbuster crop, report says
17.04.2014 / Fierce Pharma
Want to take a guess about which three new drugs are marked for greatness in 2014? One of them is obvious. Another, not so much. And the third isn't approved yet.